InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2022-05-17 00:00:00 ET · period of report 2022-05-13 · accession 0001055726-22-000042 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-17 2022-05-13 INO DANSEY ROGER D Dir M - OptEx — +12.0K 12.0K New —
D 2022-05-17 2022-05-13 INO DANSEY ROGER D Dir M - OptEx $0.00 -12.0K 24.0K -33% $0
DM 2022-05-17 2022-05-16 INO DANSEY ROGER D Dir A - Grant $0.00 +47.0K 19.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-13 M A 12,000 — 12,000 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares will vest on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2 Derivative Restricted Stock Unit 2022-05-13 M D 12,000 $0.00 24,000 D — · — to — 12,000 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares will vest on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
3 Derivative Common Stock Options 2022-05-16 A A 28,000 $0.00 28,000 D $1.89 · — to 2032-05-16 28,000 Common Stock (F3) This grant was made pursuant to the issuer's non-employee director compensation policy. (F4) Options to vest 100% on May 16, 2023.
4 Derivative Restricted Stock Unit 2022-05-16 A A 19,000 $0.00 19,000 D — · — to — 19,000 Common Stock (F3) This grant was made pursuant to the issuer's non-employee director compensation policy. (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.